Creative Planning
NVIV

Creative Planning’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Creative Planning’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– -$11K – 4454
2017
Q2 		– Hold
0
– – – 3598
2017
Q1 		– Sell
-1
Closed -$80.8K – 3251
2016
Q4 		$56K Buy
+1
New +$89.4K ﹤0.01% 2309
2016
Q3 		– Hold
0
– – – 2683
2016
Q2 		– Hold
0
– – – 2561
2016
Q1 		– Hold
0
– – – 2297
2015
Q4 		– Hold
0
– – – 2492
2015
Q3 		– Hold
0
– – – 2233

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Creative Planning's NVIV Position: Q3 2017 in Review

Creative Planning held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4454.

Creative Planning first reported a position in NVIV in Q4 2016 and has held it in 1 quarter since. The position peaked at $56K in Q4 2016. 33 funds tracked by Wall St. Rank hold NVIV as of Q3 2017.

  • Creative Planning held 0 shares of InVivo Therapeutics Holdings Corp worth $0 as of Q3 2017.
  • Creative Planning left its InVivo Therapeutics Holdings Corp share count unchanged in Q3 2017.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of Creative Planning's portfolio in Q3 2017, its #4454 holding.
  • Creative Planning first reported a position in InVivo Therapeutics Holdings Corp in Q4 2016 and has held it in 1 quarter since.
  • Creative Planning's InVivo Therapeutics Holdings Corp position peaked at $56K in Q4 2016.
  • 33 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.